Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dawn W Langdon

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Current Opinion in Neurology|April 27, 2011
Cognition in multiple sclerosisDawn W Langdon
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 24, 2017
Functional training is a senseless strategy in MS cognitive rehabilitation: Strategy training is the only useful approach - NOHanneke E Hulst, Dawn W Langdon
Neurocase|July 18, 2002
Does the spelling dyslexic read by recognizing orally spelled words? An investigation of a letter-by-letter readerElizabeth K Warrington, Dawn W Langdon
Annals of Neurology|March 9, 2023
Time to Rebaseline Cognitive Performance in People with Multiple Sclerosis?Christos Bakirtzis, Dawn W Langdon, Nikolaos Grigoriadis
Multiple Sclerosis and Related Disorders|January 29, 2021
Improving MS patients' understanding of treatment risks and benefits in clinical consultations: A randomised crossover trialGurpreet K Reen, Eli Silber, Dawn W Langdon
Patient Education and Counseling|January 22, 2017
Interventions to support risk and benefit understanding of disease-modifying drugs in Multiple Sclerosis patients: A systematic reviewGurpreet K Reen, Eli Silber, Dawn W Langdon
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 15, 2018
Best Methods of Communicating Clinical Trial Data to Improve Understanding of Treatments for Patients with Multiple SclerosisGurpreet K Reen, Eli Silber, Dawn W Langdon
Journal of the Neurological Sciences|March 22, 2017
Multiple sclerosis patients' understanding and preferences for risks and benefits of disease-modifying drugs: A systematic reviewGurpreet K Reen, Eli Silber, Dawn W Langdon
Neurologia I Neurochirurgia Polska|October 13, 2020
Polish validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS battery): correlation of cognitive impairment with mood disorders and fatigueEwa Betscher, Wojciech Guenter, Dawn W Langdon, et al.
British Journal of Health Psychology|October 13, 2006
Future-directed thinking and depression in relapsing-remitting multiple sclerosisAnna C Moore, Andrew K MacLeod, David Barnes, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Current Opinion in Neurology|April 27, 2011
Cognition in multiple sclerosisDawn W Langdon
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 24, 2017
Functional training is a senseless strategy in MS cognitive rehabilitation: Strategy training is the only useful approach - NOHanneke E Hulst, Dawn W Langdon
Neurocase|July 18, 2002
Does the spelling dyslexic read by recognizing orally spelled words? An investigation of a letter-by-letter readerElizabeth K Warrington, Dawn W Langdon
Annals of Neurology|March 9, 2023
Time to Rebaseline Cognitive Performance in People with Multiple Sclerosis?Christos Bakirtzis, Dawn W Langdon, Nikolaos Grigoriadis
Multiple Sclerosis and Related Disorders|January 29, 2021
Improving MS patients' understanding of treatment risks and benefits in clinical consultations: A randomised crossover trialGurpreet K Reen, Eli Silber, Dawn W Langdon
Patient Education and Counseling|January 22, 2017
Interventions to support risk and benefit understanding of disease-modifying drugs in Multiple Sclerosis patients: A systematic reviewGurpreet K Reen, Eli Silber, Dawn W Langdon
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 15, 2018
Best Methods of Communicating Clinical Trial Data to Improve Understanding of Treatments for Patients with Multiple SclerosisGurpreet K Reen, Eli Silber, Dawn W Langdon
Journal of the Neurological Sciences|March 22, 2017
Multiple sclerosis patients' understanding and preferences for risks and benefits of disease-modifying drugs: A systematic reviewGurpreet K Reen, Eli Silber, Dawn W Langdon
Neurologia I Neurochirurgia Polska|October 13, 2020
Polish validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS battery): correlation of cognitive impairment with mood disorders and fatigueEwa Betscher, Wojciech Guenter, Dawn W Langdon, et al.
British Journal of Health Psychology|October 13, 2006
Future-directed thinking and depression in relapsing-remitting multiple sclerosisAnna C Moore, Andrew K MacLeod, David Barnes, et al.
Pageof 2